OpGen drops on lower-than-expected 2022 prelim revenue

CapForce

18/01/2023 14:26

** Shares of diagnostics firm OpGen Inc  OPGN.O  fall ~4%
to $2.42 premarket
    ** OPGN sees FY'22 prelim revenue of about $2.7 mln, below
analysts view of $2.84 mln - Refinitiv IBES  urn:newsml:reuters.com:*:nGNX2bn2YV
    ** Says cash position, as of 2022-end, was nearly $7.4 mln
    ** OPGN stock down ~87% in the past 12 months
 (Reporting by Mariam E Sunny)
 ((Mariam.ESunny@thomsonreuters.com;))